Expert Insights
Channels
Themes
Active ETFs
ETF Investing
Alternatives
ETF Strategist
Artificial Intelligence
ETF Yield
Beyond Basic Beta
Financial Literacy
China Insights
Fixed Income
Climate Insights
Free Cash Flow
Core Strategies
Innovative ETFs
Crypto
Institutional Income Strategies
Disruptive Technology
Leveraged & Inverse
Energy Infrastructure
Modern Alpha
ETF Building Blocks
Portfolio Construction
ETF Education
Tax Efficient Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Commodities
Currency
Gold/Silver/Critical Minerals
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Exchange
Events
Exchange
Fixed Income Symposium
Alternatives Symposium
Equity Symposium
Cryptocurrency Symposium
Market Outlook Symposium
Company
About VettaFi
Get VettaFi’ed
IBB
Featured
Positive Prognosis for Biotech ETFs
By
Tom Lydon
May 10, 2013
Featured
Investors Clamor for Generic Drug ETF
By
Tom Lydon
May 6, 2013
Featured
Why Biotech ETFs are a Top Sector in 2012
By
Tom Lydon
December 19, 2012
Featured
More M&A Deals Could Boost Biotech ETFs
By
Tom Lydon
December 11, 2012
Featured
Biotech ETFs Holding Up During Rocky November
By
Tom Lydon
November 19, 2012
Featured
Sector ETFs for Obama and the Fiscal Cliff
By
Tom Lydon
November 13, 2012
Featured
Election Could Make or Break Health Care ETFs
By
Tom Lydon
September 18, 2012
Featured
ETFs and the Presidential Election
By
Tom Lydon
September 12, 2012
Featured
Biotech ETFs Cool After Strong Run
By
Tom Lydon
August 13, 2012
Featured
Follow the Next Breakthrough Drug Makers with Biotechnology ETFs
By
Tom Lydon
August 2, 2012
Featured
Biotech ETFs in ‘Stealth’ Bull Market
By
John Spence
May 31, 2012
Featured
Biotech ETFs for an M&A Boom
By
Tom Lydon
May 16, 2012
Featured
Biotech ETFs Weather Market Storm
By
John Spence
May 14, 2012
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Featured
Biotech ETFs Soar on Human Genome Bid, Gilead Drug Results
By
John Spence
April 19, 2012
Featured
Biotech ETFs Break Out
By
John Spence
January 19, 2012
Featured
Dividends, Safety Drive 2011 Sector ETF Winners
By
Tom Lydon
December 5, 2011
Featured
Biotech ETFs Mixed After Gilead Subpoena
By
Tom Lydon
June 13, 2011
Previous
1
…
18
19
20
21
22
23
Next
X